INBRACE Unveils World’s Most Advanced Fully Invisible Braces

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

“Times are changing in our industry – and we think INBRACE is the future,” said Dr. Ronald Redmond, Chairman of the Schulman Study Group an association of nationally prominent orthodontic practices from among the top one percent of all practices. “It integrates easily into any practice and allows you to grow your business without overhead because the INBRACE system uses all the tools you already have in your office. Most importantly, it makes patients happy – which is the best way to be successful.”

INBRACE, the most advanced technology ever used to straighten teeth and perfect a patient’s smile, was publicly displayed for the first time during the American Association of Orthodontists Conference in front of a capacity crowd at EvoNexus in San Diego, California. INBRACE has received more than $6M in funding to date, is FDA registered, and currently available to orthodontists and patients.

INBRACE was developed from patented technology at the University of Southern California (USC) and through an unprecedented collaboration among top dental and engineering research programs, craniofacial hospitals, and orthodontic practices in the nation. The company was co-founded by Dr. John Pham, an orthodontist, entrepreneur, and aerospace engineer, and Dr. Hongsheng Tong, a bone biologist and orthodontist.

“INBRACE has the DNA to be a billion-dollar company,” said Rory Moore, CEO and Co-Founder of EvoNexus, one of the top incubators in Southern California. “It is a perfect match of an outstanding management team and product market fit that investors have been responding to enthusiastically.”

This new style of braces hides behind the teeth and uses a space-age memory wire to perfect a patient’s smile. The product, now available through any licensed orthodontist, also significantly decreases treatment time and doctor visits for patients, establishing this new technology as the most advanced and efficient braces on the market today. INBRACE has the added benefit of allowing you to brush and floss normally and, unlike clear aligners, there is nothing to remember to put back in after eating.

“Traditional braces work well, but as most of us remember, are unattractive and not wanted by all patients, and clear aligners are actually still visible and take a long time to work because patient compliance is required,” explained Dr. Pham. “We spent the better part of a decade creating truly invisible braces that are friction free and use memory wire, and therefore can perfect your smile in significantly less time with less trips to your orthodontist.”

INBRACE has won several prestigious innovation awards and competitions leading to more than $600K of seed funding, and will be seeking Series B funding after receiving more than $5.6M of Series A funding last year.

“Times are changing in our industry – and we think INBRACE is the future,” said Dr. Ronald Redmond, Chairman of the Schulman Study Group an association of nationally prominent orthodontic practices from among the top one percent of all practices. “It integrates easily into any practice and allows you to grow your business without overhead because the INBRACE system uses all the tools you already have in your office. Most importantly, it makes patients happy – which is the best way to be successful.”

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles